Alzheimer disease and cerebrovascular pathology: an update
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Recent epidemiological and clinico-pathologic data suggest overlaps between Alzheimer disease (AD) and cerebrovascular lesions that may magnify the effect of mild AD pathology and promote progression of cognitive decline or even may precede neuronal damage and dementia. Vascular pathology in the aging brain and in AD includes: 1. cerebral amyloid angiopathy (CAA) with an incidence of 82-98% often associated with ApoE epsilon 2 and causing a) cerebral mass hemorrhages (around 70%, mainly in the frontal and parietal lobes), b) multiple or recurrent microhemorrhages (15%), and c) ischemic (micro-)infarcts or lacunes (around 20%). The frequency of these lesions increases with the severity of CAA and shows no correlation with that of senile amyloid plaques. CAA, significantly more frequent in patients with cerebral hemorrhages or infarcts than in aged controls, is an important risk factor for cerebrovascular lesions in AD. 2. Microvascular changes with decreased density and structural abnormalities causing regional metabolic and blood-brain barrier dysfunctions with ensuing neuronal damage. In large autopsy series of demented aged subjects, around 80% show Alzheimer type pathology, 20-40% with additional, often minor vascular lesions, 7-10% "pure" vascular dementia, and 3-5% "mixed" dementia (combination of AD and vascular encephalopathy). AD cases with additional minor cerebrovascular lesions have significantly more frequent histories of hypertension or infarcts than "pure" AD patients. Vascular lesions in AD include cortical microinfarcts, subcortical lacunes, white matter lesions / leukoencephalopathy, small hemorrhages and corticosubcortical infarcts, while in mixed type dementia multiple larger or hemispheral infarcts are more frequent. Small infarcts in AD patients have no essential impact on global cognitive decline which mainly depends on the severity of Alzheimer pathology, but in early stage of AD they may influence and promote the development of dementia. Recent studies showed lower density of plaques and tangles in brains with cerebrovascular lesions, and similar severity of dementia was related to fewer AD lesions in brains with than in those without small vascular lesions. Further studies will help to elucidate the risk factors and impact of cerebrovascular lesions on the development and progression of dementia in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAA appears in ≈10% to 30% of unselected brain autopsies and 80% to 100% when in the presence of accompanying Alzheimer disease.136”
In the citing paper
“which virtually all individuals with AD and about a third of aged cognitively normal individuals have) [68, 179]”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [68]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2×
“of currently used neuropathological diagnostic criteria for AD (Mirra et al., 1991; Braak and Braak, 1991; Hyman, 1998).”
BackgroundMethodMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Observations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084 · cited 2×
“…to many authors, MD should be diagnosed only if there are sufficient vascular and degenerative lesions to make each diagnosis independently (Tomlinson et al., 1970; Boller et al., 1989; Erkinjuntti, 1988; Jellinger et al., 1990; Mirra et al., 1991), while others suggest the diagnosis of AD…”
Background15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · cited 1×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 2×
“An association between hypertension and AD has been reported in several prospective studies (Skoog et al., 1993, 1996; Hofman et al., 1997; Skoog, 2000; Launer et al., 2000; Meyer et al., 2000; Schmidt et al., 2000; Kivipelto et al., 2001).”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338 · cited 2×
“that came to autopsy, but most patients had mixed disease without clear thresholds of pathological features that predicted dementia (Esiri et al., 2001).”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201 · cited 2×
“, 1991), while in the ADDTC criteria (Chui et al., 1992), a second cerebrovascular disorder in addition to AD must be shown to”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 6×
“…vessels (Claudio, 1996; Farkas et al., 2000) with increase of collagen IV (Kalaria and Pax, 1995) and breakdown of the BBB are considered important factors for disturbances of cerebral metabolism, reduced cerebral blood flow and neural metabolic changes (Shi et al., 2000; Farkas and Luiten, 2001).”
BackgroundInfluentialHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 4×
“Hypertension and hypercholesterinemia, independent of the ApoE genotype have been shown to be risk factors for AD (Hofman et al., 1997; Skoog et al., 1999).”
BackgroundInfluentialClinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Cited by
Items 601–681 of 681
Lamar, M., Wortzel, H. S., Libon, D. J., Wambach, D. M., Price, C. C., & Kumar, A. A. (2012) · Wiley eBooks · doi:10.1002/9781119968900.ch4 · Cited by 1
Gregoire, S. M. (2014) · UCL Discovery (University College London) · Cited by 3
Cerebrovascular Disease and the Expression of Alzheimer’s Disease
Esiri, M. M., & Nagy, Z. (2005) · Humana Press eBooks · doi:10.1385/1-59259-824-2:275 · Cited by 1
Charidimou, A. (2015) · UCL Discovery (University College London) · Cited by 1
Amyloid Beta and the Cerebral Vasculature
Grammas, P. (2005) · Humana Press eBooks · doi:10.1385/1-59259-824-2:267
Nicotinic modulation of cerebral microvascular permeability
Hawkins, B. T. (2005) · UA Campus Repository (The University of Arizona)
Effects of A-beta immunotherapy and Omega-3 fatty acid administration in Alzheimer's transgenic mice
Jensen, M. (2006) · Digital Commons - University of South Florida (University of South Florida)
Retinal Structural Changes in Patients with Mild Cognitive Impairment
Iordanis, D. (2015) · Clinical Medicine Research · doi:10.11648/j.cmr.s.2015040201.11
“AD is characterized by β-amyloid deposition in the wall of cerebral arteries and arterioles [32], [33], [34].”
BackgroundCracchiolo, J. R. (2005) · Digital Commons - University of South Florida (University of South Florida)
Immunomodulation As A Potential Therapeutic Approach For Alzheimer’s Disease
Nikolic, W. V. (2008) · Digital Commons - University of South Florida (University of South Florida)
Cerebrovascular Disease in the Elderly Hypertensive
Nichols, F. T. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-911-0_14
“According to data from the American Heart Association ( 2 ), more than half the population over the age of 65 years is hypertensive.”
BackgroundMethodAlzheimer's disease and dementia with Lewy bodies: Special focus on the role of serpins
Nielsen, H. M. (2007) · Lund University Publications (Lund University)
Apport de l’imagerie par résonance magnétique dans la maladie d’Alzheimer
Lehéricy, S., Boutet, C., de Souza, L. C., Chupin, M., Colliot, O., Sarazin, M., & Dormont, D. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_3
Delacourte, A., Campion, D., & Davous, P. (2007) · EMC - Neurologia · doi:10.1016/s1634-7072(07)70544-5 · Cited by 2
Ahn, B. (2007) · Nuclear Medicine and Molecular Imaging
Long-Term Treatment Response, Predictors and Biochemical Markers in Alzheimer's Disease
Wallin, Å. K. (2008) · Lund University Publications (Lund University) · Cited by 1
Molecular and clinical markers in ischaemic cerebrovascular disease
Markaki, I. (2013) · Figshare
Lacunar Infarctions and the Cognitive Decline in Patients with Parkinson's Disease
Choi, S. A., Shin, S. J., Lee, J. H., Cho, J. H., Kim, G. S., Chi, H., & Kim, J. H. (2012) · Journal of the Korean Neurological Association
Nilsson, P. M., Román, G. C., Sellke, F. W., Seshadri, S. S., Arnett, K., Bennett, D. A., Chui, H. C., Higashida, R. T., Lindquist, R. D., Nyenhuis, D. L., et al. (2011)
Chui, H. C., Higashida, R. T., Lindquist, R. D., Nilsson, P. M., Petersen, C., Schneider, J. A., Tzourio, C., Arnett, D. K., Launer, L. J., Laurent, S., et al. (2013)
Hereditary hemochromatosis : with a special emphasis on HFE genotyping
Hannuksela, J. (2004) · Cited by 2
Ocular biomarkers for early detection and monitoring of Alzheimer's disease
Frost, S. M. (2013) · UWA Profiles and Research Repository (UWA)
Morrison, J. (2015) · UWSpace (University of Waterloo) · Cited by 1
Filley, C. M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139016919.006
The Role of proteases and chaperones in extracellular proteostasis
Constantinescu, P. (2015) · Research Online (University of Wollongong)
Cheong, I. (2016) · Otago University Research Archive (University of Otago)
A patient with non-small cell lung cancer presenting with headaches and change in mental status
Mann, J. M., Tejwani, A., Baratti, C., Lavaf, A., & Parikh, K. (2012) · Community Oncology · doi:10.1016/j.cmonc.2012.02.014
“This A deposition is also closely linked to the development of Alzheimer’s disease, and study data have demonstrated a CAA incidence of between 82% and 98% in patients with Alzheimer’s disease, indicating a strong overlap between the two.(3) CAA may eventually result in lobar hemorrhages, recurrent microhemorrhages, a…”
Foster, V. (2015) · Cited by 1
Alzheimer’s disease presenting with Sudden Onset Multiple Intracranial Bleeds
(2009) · The Internet Journal of Internal Medicine · doi:10.5580/1426
Princz-Kranz, F. L. (2010) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006097535
“Vascular aspects in AD pathology comprise not only cerebral amyloid angiopathy (CAA) but also related consequences thereof such as disturbances of hemodynamic responsiveness, hypoperfusion with microinfarcts as well as microhemorrhages due to ruptures [51], [38].”
BackgroundDisturbi cognitivi di origine vascolare
Planton, M., Albucher, J., & Pariente, J. (2016) · EMC - Neurologia · doi:10.1016/s1634-7072(16)80384-0 · Cited by 1
Raya, S. P. A. B., & José, J. (2016) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Neuroinflammation in Alzheimer's Disease and Vascular Cognitive Impairment
Weekman, E. M. (2017) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2017.051
“Black arrows indicate Congo staining around a vessel (CAA).”
BackgroundInfluentialse Positron Emission Tomography/ Magnetic Resonance Imaging Current Status, Future Aspects
Rakheja, R., Chandarana, H., Ponzo, F., Seltzer, A., Beltrán, L., Geppert, C., & Friedman, K. P. (2014)
Cardiovascular and Retinal Vascular Changes in Preclinical Alzheimer's Disease
Santos, C. (2018) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-santos-claudia-2018 · Cited by 2
Faggioni, M. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-20062018-150414
Rodrigues, L. L. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2019.tde-25092019-112902 · Cited by 2
Biological Signatures of Disease in Neuro-Psychiatry as Inter-Theoretical Reduction
Stoyanov, D. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662009200331084634
Effects of anle138b treatment on amyloid-β neurotoxicity
Thomas, C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8233
The Longitudinal Relationships between Biomarkers of Alzheimer’s Disease
Krance, S. H. (2019) · TSpace (University of Toronto)
최선아, 신수정, Lee, J. H., 조정희, 김규식, 지혜진, & 김종헌 (2012)
The Role of Neuroimaging in Fall Prevention in Healthy Adults at Risk of Alzheimer's Disease
Piersson, A. D., Elshami, W., Adjei, A. N. A., Dzefi‐Tettey, K., & Gorleku, P. N. (2021) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4411-2.ch006
Cerebral amyloid angiopathy : new insights from transgenic mice
Herzig, M. C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003642738
Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
The Aging Brain: From Physiology to Neurodegeneration
Rajput, R., Kaur, R., Chadha, R., Mani, S., Rachana, R., Kaur, H., & Singh, M. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-5295-0.ch008
The Role of Neuroimaging in Fall Prevention in Healthy Adults at Risk of Alzheimer's Disease
Piersson, A. D., Elshami, W., Adjei, A. N. A., Dzefi‐Tettey, K., & Gorleku, P. N. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-5295-0.ch045
Goldenberg, G. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544880.018
Chung, J., & Chung, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-6739-1_8
Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy
Biffi, A., & Rosand, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-56210-0_5
Cencini, F., Catania, M., Fede, G. D., Rossi, G., Chalouhi, K. K., Manfredi, C., Giaccone, G., Tiraboschi, P., Bersano, A., Groppo, E., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15487
“Present in the large majority of brains with AD [28] and particularly severe in the APOE ε4 homozygous cases [29], CAA is considerably less frequent (<50%) in elderly nondemented subjects [30, 31].”
BackgroundZotin, M. C. Z. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-01122022-122130
Cerebral Amyloid Angiopathy and Intracerebral Haemorrhage
Werring, D. J., & Banerjee, G. (2016) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/jtze7333
Lowering glucose enhances BACE1 activity and Aβ generation in mouse brain slice culturesPreprint
Sheppard, O., Humphrey, R., Durrant, C. S., & Coleman, M. P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.12.584616
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24452535
Magnetic Resonance Imaging in Pharmaceutical Safety Assessment
Hockings, P. D., & Beckmann, N. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_19
The blood–brain barrier: Gatekeeper and obstacle in neurodegenerative disorders
Bassiony, M., Ibrahem, M. A., Youssef, D. G., Elbadry, A. M. M., & Alaboudi, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00002-6
Troubles cognitifs d’origine vasculaire
Planton, M., Albucher, J., & Pariente, J. (2016) · HAL
Optical Coherence Tomography in Alzheimer’s Disease
Coppola, G., Parisi, V., Casillo, F., Manni, G., & Sadun, A. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_13
Integrative Approach Towards Treatment of Alzheimer's and Other Dementias
Khan, N. A., Sambyal, N., Tanzeelah, Sachdeva, P., Siwan, D., Rehman, A., Dey, A., Ghosh, S., Mahajan, A. A., Rizvi, S., et al. (2025) · Advances in Integrative Medicine · doi:10.1002/9781394336807.ch8
Purrucker, R., & Buschner, A. (2025) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-025-04130-5
“Dies steht in Einklang mit medizinischen Studien, welche kardiovaskuläre Erkrankungen als relevanten Risikofaktor für Demenz herausarbeiten konnten [20, 21].”
Stroke caused by cerebral amyloid angiopathy: a case of difficult diagnosis
Gamarra, R., Villanueva-Colina, C., & Garcia, J. P. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2025-0288
Alcohol use as a potential moderator of risk factors for Alzheimer's disease
Stelmokas, J. (2013) · CommonKnowledge Research Repository (Pacific University Oregon)
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24452610
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26633139
Zhang, Q., Coury, R., & Tang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26691178
Walker, L., Simpson, H., Thomas, A. J., & Attems, J. (2024) · Figshare · doi:10.6084/m9.figshare.26681218
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26633136
Zhang, Q., Coury, R., & Tang, W. (2024) · Figshare · doi:10.6084/m9.figshare.26691181
Xu, Y. (2016) · theses.fr (ABES) · doi:10.70675/39ceb0d5zfd48z4e4fz84f0z597eb08381d7 · Cited by 1
Troubles neurocognitifs légers et majeurs post-AVC : prévalence et contribution de l'amyloïdopathie
Barbay, M. (2021) · theses.fr (ABES) · doi:10.70675/dd65ad73z6500z49afza101z4be85b3bd396
Toma, C., & Vujosevic, S. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00022-7
Mulholland, M. M., Magden, E. R., Scholtzova, H., & Hopkins, W. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.735676 · Cited by 1
“In addition, many AD cases involve cerebral amyloid angiopathy (CAA), a condition in which A β build up occurs in the brain’s blood vessels (Greenberg & van Veluw, 2024; Jellinger, 2002).”
Angiogenic Mediators and the Pathogenesis of Alzheimer’s Disease
Grammas, P. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_13
Factors associated with intracerebral hemorrhage in confirmed cerebral amyloid angiopathy
Chaachou-Charradi, A., Burgueño‐García, I., Camacho, J., Moliné, T., Zagrean, N., y Cajal, S. R., Rábano‐Gutierrez, A., Martínez-Sáez, E. A., & Hernández‐Guillamón, M. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71786
“10 Thus, CAA is a common copathology of AD, but both conditions differ in their mechanisms of brain injury, despite sharing a common pathophysiological substrate based on A β protein deposition.”
Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact
Lopez, F. V., Erani, F. R., Bangen, K. J., Coughlin, D. G., Galasko, D. R., & Thomas, K. R. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70531
“Additionally, postmortem studies have documented the frequent co-occurrence of AD in persons with PD-MCI and PDD, suggesting co-pathology may be the rule rather than the exception [13–15, 19, 27].”
López, Á., & Jesús, M. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Inhibition of Amyloid Beta-Protein Fibrillogenesis by Myelin Basic Protein
Hoos, M. D. (2009) · Academic Commons (Stony Brook University)
Metadata
- Authors
- Jellinger, K. A.
- Affiliations
- Ludwig Boltzmann für Klinische Neurobiologie (AT)
- Corresponding author
- Jellinger, K. A.
- ORCID
- Jellinger, K. A.
- Venue
- Journal of Neural Transmission
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 5-6
- Pages
- 813-836
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2084675121
- Cited by
- 680
- References
- 114
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 32 · 2023: 19 · 2022: 38 · 2021: 32 · 2020: 22 · 2019: 26 · 2018: 23 · 2017: 22 · 2016: 30 · 2015: 44 · 2014: 38 · 2013: 27 · 2012: 39
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebrovascular pathology, cerebral amyloid angiopathy, cerebral hemorrhage, microinfarcts, lacunes, white matter lesions, mixed dementia, vascular dementia, cognitive decline, dementia progression, blood-brain barrier dysfunction
- MeSH terms
- Alzheimer Disease, Blood Vessels, Cerebrovascular Circulation, Cerebrovascular Disorders, Diagnosis, Differential, Humans, Microcirculation, Risk Factors, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.